Image

Evaluating the Prognostic Capability of ctDNA as a Biomarker in Pancreatic Cancer Patients Undergoing Neoadjuvant Chemotherapy

Studying ctDNA's role in predicting outcomes for pancreatic cancer treatment.

Recruiting
18 years and older
All
Phase N/A
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study is for people with pancreatic cancer that hasn't spread far. The goal is to see if we can find cancer DNA in the blood. This special kind of DNA is called circulating tumor DNA (ctDNA). Doctors think that checking for ctDNA could help them understand how the cancer reacts to treatments like chemotherapy (cancer medicine) and surgery. By studying ctDNA, future treatments might improve for new patients. The study looks at ctDNA before, during, and after treatment to see how it changes and if it can help decide what treatments to try next.

  • The study is for adults 18+ with specific pancreatic cancer.
  • Participants need to undergo chemotherapy for non-metastatic pancreatic cancer.
  • Cannot join if cancer has spread to other parts of the body.
Print
Study details
    Pancreas Cancer

NCT04616131

Northwestern University

6 August 2026

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.